We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Moderate to strong cytoplasmic positivity was found in colorectal, breast, melanomas and gynaecological cancers. Remaining cancer tissues were generally negative.
A majority of cancer tissues showed moderate to strong cytoplasmic and nuclear staining. Liver, pancreatic, renal, urothelial, testicular cancers were negative in a majority of cases.
This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]
Phobius predicted membrane proteins Predicted intracellular proteins Plasma proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Splicing Mutations COSMIC Somatic Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Large Deletions COSMIC Germline Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000209 [protein polyubiquitination] GO:0000422 [mitophagy] GO:0002039 [p53 binding] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005730 [nucleolus] GO:0005739 [mitochondrion] GO:0006351 [transcription, DNA-templated] GO:0006364 [rRNA processing] GO:0006469 [negative regulation of protein kinase activity] GO:0006915 [apoptotic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007050 [cell cycle arrest] GO:0008134 [transcription factor binding] GO:0008285 [negative regulation of cell proliferation] GO:0008637 [apoptotic mitochondrial changes] GO:0010389 [regulation of G2/M transition of mitotic cell cycle] GO:0016604 [nuclear body] GO:0016925 [protein sumoylation] GO:0030889 [negative regulation of B cell proliferation] GO:0031647 [regulation of protein stability] GO:0031648 [protein destabilization] GO:0033088 [negative regulation of immature T cell proliferation in thymus] GO:0033235 [positive regulation of protein sumoylation] GO:0043065 [positive regulation of apoptotic process] GO:0043234 [protein complex] GO:0043517 [positive regulation of DNA damage response, signal transduction by p53 class mediator] GO:0043687 [post-translational protein modification] GO:0044267 [cellular protein metabolic process] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046825 [regulation of protein export from nucleus] GO:0048103 [somatic stem cell division] GO:0050821 [protein stabilization] GO:0051444 [negative regulation of ubiquitin-protein transferase activity] GO:0051882 [mitochondrial depolarization] GO:0055105 [ubiquitin-protein transferase inhibitor activity] GO:0070534 [protein K63-linked ubiquitination] GO:0071158 [positive regulation of cell cycle arrest] GO:0090398 [cellular senescence] GO:0097371 [MDM2/MDM4 family protein binding] GO:1900182 [positive regulation of protein localization to nucleus] GO:1901798 [positive regulation of signal transduction by p53 class mediator] GO:1902510 [regulation of apoptotic DNA fragmentation] GO:1903051 [negative regulation of proteolysis involved in cellular protein catabolic process] GO:1903214 [regulation of protein targeting to mitochondrion] GO:2000059 [negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process]
Phobius predicted membrane proteins Predicted intracellular proteins Plasma proteins Cancer-related genes Mutated cancer genes Mutational cancer driver genes COSMIC somatic mutations in cancer genes COSMIC Splicing Mutations COSMIC Somatic Mutations COSMIC Nonsense Mutations COSMIC Missense Mutations COSMIC Large Deletions COSMIC Germline Mutations COSMIC Frameshift Mutations Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000209 [protein polyubiquitination] GO:0000422 [mitophagy] GO:0002039 [p53 binding] GO:0003677 [DNA binding] GO:0005515 [protein binding] GO:0005634 [nucleus] GO:0005654 [nucleoplasm] GO:0005730 [nucleolus] GO:0005739 [mitochondrion] GO:0006351 [transcription, DNA-templated] GO:0006364 [rRNA processing] GO:0006469 [negative regulation of protein kinase activity] GO:0006915 [apoptotic process] GO:0006919 [activation of cysteine-type endopeptidase activity involved in apoptotic process] GO:0007050 [cell cycle arrest] GO:0008134 [transcription factor binding] GO:0008285 [negative regulation of cell proliferation] GO:0008637 [apoptotic mitochondrial changes] GO:0010389 [regulation of G2/M transition of mitotic cell cycle] GO:0016604 [nuclear body] GO:0016925 [protein sumoylation] GO:0030889 [negative regulation of B cell proliferation] GO:0031647 [regulation of protein stability] GO:0031648 [protein destabilization] GO:0033088 [negative regulation of immature T cell proliferation in thymus] GO:0033235 [positive regulation of protein sumoylation] GO:0043065 [positive regulation of apoptotic process] GO:0043234 [protein complex] GO:0043517 [positive regulation of DNA damage response, signal transduction by p53 class mediator] GO:0043687 [post-translational protein modification] GO:0044267 [cellular protein metabolic process] GO:0045893 [positive regulation of transcription, DNA-templated] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0046825 [regulation of protein export from nucleus] GO:0048103 [somatic stem cell division] GO:0050821 [protein stabilization] GO:0051444 [negative regulation of ubiquitin-protein transferase activity] GO:0051882 [mitochondrial depolarization] GO:0055105 [ubiquitin-protein transferase inhibitor activity] GO:0070534 [protein K63-linked ubiquitination] GO:0071158 [positive regulation of cell cycle arrest] GO:0090398 [cellular senescence] GO:0097371 [MDM2/MDM4 family protein binding] GO:1900182 [positive regulation of protein localization to nucleus] GO:1901798 [positive regulation of signal transduction by p53 class mediator] GO:1902510 [regulation of apoptotic DNA fragmentation] GO:1903051 [negative regulation of proteolysis involved in cellular protein catabolic process] GO:1903214 [regulation of protein targeting to mitochondrion] GO:2000059 [negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process]